MBX Biosciences Company

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Last Funding Type: Series A
Funding Status: Early Stage Venture
Headquarters: Carmel, Indiana, United States
Founded Date: 2019
Investor Type: For Profit
Total Funding: $59.9M
Technology: Others
Employee Number: 1-10
Estimated Revenue: $1M to $10M
Investors Number: 6
Industry: PharmTech